Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
08/2000
08/31/2000WO2000007996A3 Pyrazoles as estrogen receptor modulators
08/31/2000DE19908762A1 Verwendung von Dienogest in hoher Dosierung Use of dienogest in high doses
08/31/2000DE19908041A1 Kovalent verbrückte Insulindimere Covalently bridged insulin dimers
08/31/2000CA2850318A1 Trpm-2 antisense therapy
08/31/2000CA2371814A1 Trpm-2 antisense therapy
08/31/2000CA2363621A1 A novel inhibitor of programmed cell death
08/31/2000CA2362533A1 Gene sequence variations with utility in determining the treatment of disease
08/31/2000CA2362099A1 T cell receptor v.beta.-d.beta.-j.beta. sequence and methods for its detection
08/30/2000EP1031575A1 Process for preparing growth hormone secretagogues
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/30/2000EP1030661A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA 2? INHIBITORS
08/30/2000CN1265037A Soya extract, process for its prepn. and pharmaceutical compsn.
08/30/2000CN1055848C Traditional Chinese patent drugs for curing gastrointestinal tract disease and gynopathy
08/29/2000US6110935 A promoter for n-methyl-d-aspartic acid (nmda) receptors, useful for such therapeutic purposes as facilitating the learning of behaviors, treating schizophrenia, memory impairment
08/29/2000US6110932 Increase the level of endogenous growth hormone for the treatment and prevention of osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair, accelerating wound healing
08/29/2000US6110931 For pregnancy prophylaxis and treatment of glandular disorders, hormone deficiency disorders, gastrointestinal disorders, growth disorders
08/29/2000US6110906 Androgen derivatives for use in the inhibition of sex steroid activity
08/24/2000WO2000049050A2 Use of blocking anti-tsh-receptor-antibodies in the therapy of hyperthyreoses and monoclonal antibodies for a use of this type
08/24/2000WO2000049037A1 Growth hormone secretagogues
08/24/2000WO2000049015A1 Pyridine compounds and their pharmaceutical use
08/24/2000WO2000048989A1 Mevinolin derivatives
08/24/2000WO2000048643A1 Biodegradable, injectable oligomer-polymer composition
08/24/2000WO2000048627A1 Inhibitors of separin, method for identifying them and uses
08/24/2000WO2000048605A1 Agent acting on the hypothalamus and the pituitary gland and having an action on the sexual cycle of domestic animals, and variants
08/24/2000WO2000048604A1 Utilization of dienogest in high doses
08/24/2000WO2000015797A3 Compositions and methods for the treatment of immune related diseases
08/24/2000WO2000012685A3 Genes associated with neurotransmitter processing
08/24/2000DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha
08/24/2000DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs
08/24/2000CA2362538A1 Secreted proteins and polynucleotides encoding them
08/24/2000CA2362303A1 Growth hormone secretagogues
08/23/2000EP1029547A1 Pharmaceutically active compounds and method for identifying same
08/23/2000EP1028731A2 Stable antiandrogenic gel composition
08/23/2000EP1028709A1 Novel once-a-day controlled release sulfonylurea formulation
08/23/2000EP0640072B1 Derivatives of pyridine as hydroxylase and lyase inhibitors
08/23/2000EP0637297B1 Compounds having selectivity for retinoid x receptors
08/23/2000CN1264384A Fused 1,2,4-thiadiazine derivatives, their preparation method and use
08/23/2000CN1264381A 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
08/23/2000CN1264302A Treatment of diabetes with thiazolidinedione and sulphonylurea
08/23/2000CN1055700C Therapeutic peptide derivatives
08/23/2000CN1055623C Chinese drug for prevention of mammary gland hyperplasia
08/22/2000US6107517 Thyroid hormone agonists and antagonists
08/22/2000US6107306 Heterocyclic compounds
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/17/2000WO2000047741A1 Glycosylated leptin compositions and related methods
08/17/2000WO2000047720A2 Pancreatic progenitor cells, methods and uses related thereto
08/17/2000WO2000047603A2 16-hydroxyestratrienes as selective estrogens
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047577A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
08/17/2000WO2000047237A1 Encapsulated cells containing an amplified expression vector as a drug delivery device
08/17/2000WO2000047219A2 Methods and reagents for treating glucose metabolic disorders
08/17/2000WO2000047201A1 The pharmacological use of certain cystine derivatives
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000047191A1 Laminates containing an active substance for transdermal systems
08/17/2000WO2000047188A1 Oxadiazole compounds and compositions for delivering active agents
08/17/2000WO2000047149A1 Gels formed by the interaction of poly(aldehyde) with various substances
08/17/2000WO2000009109A3 Pipecolic acid derivatives for vision and memory disorders
08/17/2000DE19906152A1 Wirkstoffhaltige Laminate für Transdermalsysteme Active substance laminates for transdermal
08/17/2000CA2362593A1 Pancreatic progenitor cells, methods and uses related thereto
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360324A1 Peptide yy (pyy) for inducing glucose responsiveness in pancreatic islets
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/17/2000CA2360123A1 Encapsulated cells containing an amplified expression vector as a drug delivery device
08/17/2000CA2359660A1 16-hydroxyestratrienes as selective estrogens
08/16/2000EP1028110A1 Novel dihydronaphthalene compounds and process for producing the same
08/16/2000EP1027891A2 Neuropeptide y antagonists
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP0902790B1 Process for preparing steroids having a carboxamide side-chain
08/16/2000EP0883628B1 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof
08/16/2000CN1263535A LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
08/16/2000CN1263469A Pharmaceutical compositions of peptides having low solubility in physiological medium
08/16/2000CN1055471C Substituted imidazolidines, their preparing process, and intermediates, their pharmaceutical compositions and there use
08/15/2000US6103874 Human KDEL receptor
08/15/2000US6103742 Administering to said patient a therapeutically effective amount of an insulin sensitivity enhancer in combination with a statin compound to treat diabetes
08/15/2000US6103737 Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists
08/10/2000WO2000046351A2 Platform for the differentiation of cells
08/10/2000WO2000046234A1 11.beta.[p-(n-dimethylamino)-phenyl]-estra-4,9-dien-3-on derivatives with spiro-lactol substitution in position 17 as antiprogestomimetic agents
08/10/2000WO2000046225A2 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
08/10/2000WO2000045816A1 Calcilytic compounds
08/10/2000WO2000045815A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000WO2000045795A2 Topical sprays comprising a film forming composition
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000045790A2 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000024360A3 Preparation and use of solidified oils
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
08/10/2000CA2361589A1 Calcilytic compounds
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361046A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000CA2359821A1 Platform for the differentiation of cells
08/10/2000CA2358895A1 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
08/09/2000EP1025125A1 Aggregates of human insulin derivatives
08/09/2000EP1025106A2 Allosteric adenosine receptor modulators
08/09/2000EP1025100A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
08/09/2000EP1025098A1 Benzothiophenes
08/09/2000EP1025077A1 Novel aryloxy-alkyl-dialkylamines
08/09/2000EP1024815A1 Pharmaceutical compositions for oral administration of molecular iodine
08/08/2000US6100294 For treatment of metabolic, glandular, and bone disorders caused by vitamin deficiency
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 290